Dr George Fareed and Dr Brian Tyson, experts in virus treatment and emergency care, cured more than 7,000 patients of Covid-19 against enormous opposition with a simple repurposed drug cocktail. Here’s their own story of how they did it and why it was suppressed.
Viruses causing pneumonia, bronchitis and other upper respiratory conditions are common in the medical field. We expect these viruses to be ordinary.
In most cases of viruses, we treat the patient with what is considered a classic protocol. Then, within a week to 10 days, the patients improve and life goes on as usual.
But the Covid virus was anything but ordinary—like nothing we have ever seen or experienced. We just didn’t realize it at the time.
On January 24, 2020, patient samples obtained in Wuhan allowed the SARS CoV2 virus to be identified and characterized for the first time. In those early days, there was no known effective treatment. In fact, many people were simply being told to go home from the hospital and “wait it out”—and only to return to the hospital if the virus became life-threatening.
As we all know, in too many of these cases, returning to the hospital was too late for that person to recover and survive the deadly virus. This approach had horrific consequences. Wait at home, then, if you’re really sick, go to the hospital, where you can be put on a ventilator. Then wait again and hope for a miracle.
For far too many individuals, their miracle never showed up. If only they could have been tested early. If only they could have received an effective treatment immediately—even before the test results were in. If only.
Dr George Fareed is the son of the legendary medical missionary Dr Omar John Fareed, who worked with Dr Albert Schweitzer, and he trained at Harvard Medical School, studying recombinant DNA. He went on to teach at Harvard and UCLA Medical Schools, carried out biotech research resulting in three US patents, and served as a medical missionary in Africa and team physician for the US Davis Cup tennis teams before becoming a family doctor for patients in Brawley, California. Dr Fareed also established the first HIV clinic in Brawley, administering repurposed drug cocktail treatments before they became the standard of care during the AIDS epidemic.
Dr Fareed built on his knowledge of treating viruses with drug cocktails and high-dose supplements when the Covid pandemic struck. Early in the pandemic, Dr Fareed teamed up with Dr Brian Tyson, a young urgent care specialist who owns and operates All Valley Urgent Care in El Centro, California. Among his thousands of Covid patients were migrant farm workers and meat-packing house employees.
Together, the two physicians led the nation in using repurposed drug cocktails to treat Covid patients, despite the media and official positions against the use of hydroxychloroquine for Covid.
Dr Fareed and Dr Tyson have now treated over 7,000 patients with Covid-19—and saved every one of them with no ill effects. Not a single death occurred with early treatment. Only four hospitalizations happened under their watch, and unfortunately, they lost three individuals who presented to the clinic too late in the disease to be treated as outpatients.
But instead of receiving a Nobel Peace Prize or a Presidential Medal of Freedom, Dr Tyson was told his license might be in jeopardy if he continued treating patients with their cocktail.
We found that a combination of hydroxychloroquine, zinc and antibiotics could serve as an extremely effective treatment, if they were administered as early as possible. In fact, our results are nothing short of a miracle.
When the pandemic became a reality in March 2020, both of us elected to use an agent that had previously been shown to be an effective antiviral against coronaviruses like Covid-19.
Hydroxychloroquine had already been in use in France when Dr Didier Raoult— director of the Infectious Disease Center in Marseille, France, and a world-renowned specialist in tropical diseases and infectious diseases—produced what appeared to be excellent benefits for preventing hospitalization and death.
The protocol for its use in New York by Dr Vladimir Zelenko, a family practice physician in upper New York who pioneered the early use of hydroxychloroquine, zinc and azithromycin, showed encouraging results as well.
We decided to use hydroxychloroquine in a protocol utilizing a somewhat higher dose, but nothing at all toxic or dangerous. Most of the protocols used the hydroxychloroquine in doses of approximately 2,400 milligrams over five to eight days.
In our protocol, we utilized hydroxychloroquine at 3,200 mg over five days of treatment (based on the higher dosages Dr Raoult was using). We found the key for effective treatment was employing the protocol with this antiviral agent in the early phase of the infection of Covid-19—no later than 10 to 14 days of infection, and preferably within the first three to five days.
In the early months of the pandemic, at both the urgent care and Brawley clinics at the Pioneers Hospital, we saw hundreds and hundreds of symptomatic adult patients in need of early treatment to prevent the consequences of viral spread and damage in the lungs and other major organs.
Unfortunately, instead of receiving encouragement for our work, we faced criticism. In fact, we were even threatened with professional sanctions if we continued our life-saving protocols. Despite those threats, we persisted, as we saw too many other professionals in our field stand idly by, watching patients needlessly die in their care.
Fortunately, being in a rural area detached us somewhat from academic influences. This gave us the freedom to do what we knew worked. By following our effective protocol, were also able to witness extraordinary improvements and the resolution of symptoms in our patients.
We began screening patients outside with a pop-up tent, tables and some chairs.
We started treatment on patients, beginning with 400 mg of hydroxychloroquine by mouth twice a day on the first day, then 200 mg three times a day for days two through five. After two to three days, patients were re-evaluated, and they would return between seven and 14 days to ensure they improved. We also wanted to confirm immunity for patients who needed to return to work.
As the pandemic raged on throughout the spring and into the summer, the world learned more and more each day about Covid-19. First and foremost, contrary to what we were first told, this was not a natural evolution of the coronavirus from animal species into humans—making the opposition we faced completely unethical (and possibly criminal).
It’s unconscionable that early treatment was not being offered for something that was actually a “super” virus: genetically enhanced in a laboratory and made much more likely to be extraordinarily dangerous for humans.
Then, in May of 2020, a beacon of light shone through the darkness, in the form of a very well-written article in the American Journal of Epidemiology by Dr Harvey Risch from Yale University.1 He supported early treatment with hydroxychloroquine to stem the growing numbers of hospitalizations and fatalities resulting from Covid-19.
There were 50,000–60,000 fatalities at that time, and Harvey Risch predicted there might be 100,000 dead by the end of June if this protocol was not initiated.
In his Senate testimony, Dr Risch stated, “What I have observed is that while there have been positive reports about a number of drugs, every student of outpatient use of one drug, hydroxychloroquine, with or without accompanying agents, has shown substantial benefit in reducing risks of hospitalization and mortality.”2
Despite the success of the hydroxychloroquine treatment protocol, and despite the 100 percent success rate for our patients who were treated early, the unthinkable happened: the National Institutes of Health (NIH), Food and Drug Administration (FDA), World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) knowingly blocked effective early treatment for a virus enhanced in a lab to infect and kill humans. The reason? To sell a vaccine that turned out to be significantly ineffective in blocking new infections by variants.
If you’re wondering why the development of a vaccine has anything to do with the hydroxychloroquine treatment, then it’s vital to understand a few important details about Emergency Use Authorizations (EUAs). The Covid vaccines were allowed to be administered because they were given an EUA.
However, according to the FDA, an EUA may be granted only if there is “no adequate, approved, and available alternative to the candidate product for diagnosing, preventing, or treating the disease or condition.”
In other words, an EUA is possible only if there is no other safe, effective treatment. Therefore, hydroxychloroquine—and later ivermectin—had to be defeated.
Consider just a few of our patients’ stories, as they were told to reporters of The Desert Review and Calexico Chronicle, and decide for yourself:
• Jim Hanks, age 74, is a well-known local figure in the Imperial Valley. When Hanks began experiencing symptoms of respiratory complications from Covid-19, his cousin reached out, seeking help from Dr Fareed. This, after Hanks had been discharged from the emergency room to basically fight it off at home or come back when he could not breathe.
“I can’t say enough about Dr Fareed. I am living proof his protocol works, and I took it late. In prescribing the medications, Dr Fareed explained precisely how they would affect me and when I should start feeling better. He was spot-on, including oxygen levels and body temperature.” As for cost? That week’s dose of the prescribed medicine cost him a mere $37.
• Another couple, Charlie and Meg Slater, said that after they tested positive for Covid, “Dr Fareed immediately made arrangements for us to go to the Emergency Room at PMH for the monoclonal infusions, as well as instructing us to begin taking his ‘Covid Cocktail’ protocol.”
Charlie explained that initially there were “no head cold symptoms for my wife, although I still had a bit of a chest cough. The next few days followed with extreme fatigue, and finally [we lost] our sense of taste and smell, so we rested.” Two days after the infusions, both noticed a significant improvement and felt “back to normal” despite Charlie’s history of serious health problems over the last few years.
• Imperial resident Dionte Bell said he thinks he caught Covid while working either the vehicle lanes or the pedestrian lanes at the Calexico West Port of Entry in early July 2020. After getting to the point where he already had no sense of taste and experienced shortness of breath, a blinding headache, and a fever that would not go away, he walked into the ER at Pioneers Memorial Hospital on Sunday, July 12, 2020. A healthy man who regularly lifts weights and exercises, Bell took a Covid test and was told to go home and isolate until the results came back. He wasn’t given any medication and didn’t get any results back until July 14 or 15.
As he began feeling worse, he called his physician on July 22—10 days after being tested. Dr Fareed immediately called in a five-day course of the hydroxychloroquine cocktail. “It felt really strong at the beginning; it made my heartbeat rise,” Bell remembers. “But after a day or two, I got used to it.” What amazed Bell, though, was the very night he began taking the cocktail, he could feel his symptoms start to subside, his fever relented, and his headache went away.
These are real people we treated, along with thousands more.
Covid-19 is part of the coronavirus family. This meant we needed to prepare for something likely transmitted via droplet or aerosol.
With the first patients coming in we began to use the protocol as planned. In chest X-rays we noticed the radiographs revealed a patchy consolidation pattern, while the lungs themselves remained clear. This told us it was not consolidation, but more likely interstitial or inflammation causing the changes.
We discussed how we normally treated asthma patients with Solu-Medrol, a methylprednisolone or steroid, and wanted to see how it would work. We planned to give 125 mg of Solu-Medrol intramuscular injection to patients affected by the virus and then revisit those patients two to three days later to recheck their chest X-rays.
While treating our patients at the urgent care center, we continued to monitor and study the findings from other frontline physicians from around the country. We later changed to dexamethasone (a glucocorticoid medication) when the dexamethasone studies showed higher benefits for hospitalized patients. This change in medication was also good for the patient due to the inherent pain accompanying Solu-Medrol injections.
Dr Richard Bartlett, an emergency and primary care physician from Texas, then came out with his findings on the benefits of inhaled budesonide that appeared to help tremendously in Covid patients. We added this medicine in the nebulized form with albuterol to improve oxygenation in our patients.
At the time, nebulized medications (converting liquid medication to a fine spray for inhalation) in Covid-19 were not being utilized in other hospitals because of the fear of spreading the virus to healthcare workers.
But this decision was extremely worrisome for asthmatics. We had multiple asthmatics show up at our urgent care center for nebulizer treatments and intravenous Solu-Medrol, due to their inability to receive treatments in the local emergency rooms.
Other findings were blood clots and heart attacks in patients presenting with severe symptoms of Covid-19. This was when we added anticoagulants, such as aspirin or apixaban, to our treatment to prevent these complications. It was not serendipitous that we came up with these successful treatments; it simply stemmed from following and treating the complications, signs and symptoms we were seeing.
Several doctors and medical professionals around the country—and even the world—have come face-to-face with how best to treat their Covid-19 patients, many relying on hydroxychloroquine, zinc and an antibiotic—now known commonly as the hydroxychloroquine cocktail.
By the end of March and April 2020, we were seeing 200–400 patients a day. Many essential workers asked for assistance in keeping their services and businesses open, too.
We took care of the many local agencies, including the US Border Patrol, Calipatria and Centinela State Prison corrections officers, the Department of Homeland Security, US Customs, the county sheriff’s office, the One World Beef Plant, local manufacturing businesses, multiple automobile dealerships, school districts and Imperial County employees.
Many cattle feed and farming seed companies’ employees sought us out, as well as various medical and dental offices that needed to stay open. By revising the tents and tables inside an insulated carport with mobile clinical functions implemented, it was possible to enable air conditioning during the summer and keep copy machines, registration kiosks and disinfection protocols humming along.
Here is our most updated and successful protocol to date.
Day 1
Days 2–5
If respiratory symptoms present:
Alternative Covid-19 early treatment regimen:
Start if you get Covid-19
If respiratory symptoms increase (worsen):
During this, we were contacted by the Imperial County Public Health Office. They asked us to stop testing because we were creating too much work for them. When we asked where else we could send them for confirmation, we were told to send patients to the emergency room.
Then we received a letter from the ER medical director at El Centro Regional Medical Center instructing us to stop prescribing hydroxychloroquine because it would prohibit the hospitals from procuring it for those who needed it.
We could not believe what we were hearing. For the first time in our lives as a physicians, we were being told to stop saving people’s lives!
Our response was clear: “Give us an alternative, and we will use it. Until then, we will use whatever we have that has been shown to work.”
Our protocol with a hydroxychloroquine backbone helped Covid-19 patients rapidly improve; in fact, the regimen has not yet failed the team since March 2020. After eight months of following this protocol, we added ivermectin to enhance the treatment.
This principle was consistent with nearly 30 years of experience in treating HIV: one always employs two or three different antivirals with different mechanisms of action against HIV for successful treatment.
In our current Covid-19 protocol, there are effectively four antivirals: the main two are hydroxychloroquine and ivermectin, while the secondary antivirals are antibiotics that have weak antiviral actions: doxycycline or azithromycin.
Zinc rounds out the protocol, as it inhibits the Covid-19 RNA-dependent polymerase (an enzyme that is key to the virus’s replication). Acting intracellularly to accomplish this inhibition, zinc’s entry into the cell is facilitated by hydroxychloroquine, a zinc ionophore, which is a chemical species that reversibly binds ions.3 Zinc is a positively charged metal element that needs a transporter or ionophore to pass through from the outside into the interior of living cells.
Vitamin D3 also acts as a zinc ionophore, and patients with low vitamin D levels are more vulnerable to Covid-19 infection complications.
Finally, we add a 325-mg dose of aspirin for protection against clotting and thrombosis (late complications of Covid-19).
Armed with this powerful protocol, we pleaded throughout June and July for our representatives in Congress and the health department to see our successful treatment—but to absolutely no avail.
Despite the amazing success we achieved with more than 7,000 patients, all of the major medical organizations—from the WHO, to the NIH, to the CDC—did not welcome our information. Rather, they attempted to stop us from effectively treating patients, as well as to suppress the information we knew the public needed to hear.
We were even threatened with professional consequences if we were to continue providing this life-saving treatment to Covid-positive individuals.
Dr Didier Raoult The famous French microbiologist and his colleagues have published scores of papers, including one summarizing the use of hydroxychloroquine early treatment protocols applied to approximately 8,000 patients, with just five deaths, as of sometime in 2021.5
Dr Ben Marble Dr Marble, a Florida family medicine specialist, is the first physician to treat patients in all 50 states. He and his staff have treated 65,000 patients in the early stages of Covid-19 with what he describes as a 99.99 percent survival rate—in the ballpark of six or seven total deaths.
Dr Vipul Shah As of June 2021, Dr Shah, a specialist in infectious illness in Gujarat, India, had lost just five out of around 8,000 patients using hydroxychloroquine during the first pandemic wave in India, then ivermectin during the second. He switched treatment protocols due to Facebook’s censoring of his communication with other physicians and patients.
Dr Vladimir Zelenko At Columbia University Medical Center, the late Dr Zelenko used what he called the Zelenko Protocol to treat around 3,000 patients, and only two died.
Dr Brian Procter Through September 2020, Dr Procter, a family medicine specialist in McKinney, Texas, put 922 patients through his treatment protocol with six hospitalizations and one death. We lost track of his tally after Twitter revoked his account.
Dr Luigi Cavanna By April 2020, Dr Cavanna, head of hematology and oncology at the Guglielmo da Saliceto hospital in Italy, stated in an interview with Time that he had treated 280 outpatients in Covid-ravaged Italy with around 5 percent hospitalization and zero deaths. The media stopped reporting on his success, but Italy begin treating far larger numbers of outpatients and using hydroxychloroquine for most inpatients after word of his success spread.
Pharmacist Abdulrahman Mohana At the Saudi Center for Disease Prevention and Control, Senior Clinical Pharmacist Mohana led a study of 238 outpatient fever clinics prescribing hydroxychloroquine to 2,733 Covid-19 patients in Saudi Arabia and reported no ICU admissions or deaths.
Dr Heather Gessling By September 2021, the top-ranked family physician in Columbia, Missouri, had treated around 1,500 patients, losing just one due to nonadherence to treatment. She was later fired as chief of staff from the hospital where she worked.
Dr John Littell Dr Littell, a Florida family physician who has practiced for over 25 years, treated well over 2,000 patients early and reported only around 10 deaths (all Delta variant infections).
Dr Mollie James A surgeon and critical care specialist based in Chariton, Iowa, Dr James has treated around 1,000 patients, with five hospitalizations (all arriving relatively late for treatment among the early treatment patients) and zero deaths.
Dr Ryan Cole Dr Cole, an Idaho pathologist, treated around 350 patients with zero hospitalizations and zero deaths.
Dr Pierre Kory A specialist in pulmonary and critical care and a cofounder of the Front Line Covid-19 Critical Care Alliance, Dr Kory has treated between 150 and 200 patients with one hospitalization and no deaths.
Dr Kimberly Milhoan An anesthesiologist at Maui Memorial Medical Center, Dr Milhoan has treated around 200 Covid patients, with a few hospitalizations and zero deaths.
Dr Katarina Lindley Dr Lindley, a Texas family medicine and urgent care physician, has treated around 100 patients, with five hospitalizations and zero deaths.
Dr Deborah Chisholm As a family physician, Dr Chisholm operates a clinic in rural Illinois that has treated around 100 Covid patients with zero deaths.
What we see in these results is repetition. And consistency. The 100,000 or so patients represented here suffered around 30 total deaths, which comes out to a 99.97 percent survival rate.
Why would anyone want to stop getting the word out, when a pandemic that rocked the globe could be effectively treated? Why would doctors on the front lines, saving lives each day, be threatened with punishment from their own colleagues?
When the world was desperate to find a treatment or cure for a deadly disease, and when we actually provided that information . . . it was censored.
Despite making congressional statements, providing data to prove our success rates, and offering thousands of anecdotal stories of treatment and recovery, we found the CDC, NIH or any other medical organization would not listen. They were too busy telling the public that there was no cure.
Sadly, some medical academics published patently false information early on. Many flawed clinical trials were guided and published by individuals with vast conflicts of interest never disclosed.
To appease these academics, medical institutions and official agencies essentially blocked all early treatment protocols using hydroxychloroquine.
Even though that false information was later retracted, the damage was done: our work was being discounted, and people continued to believe misinformation as they blindly accepted certain doctors’ recommendations as gospel.
Covid-19 infections had been curtailed early in the first phase of the illness with readily available, inexpensive and effective treatment. The massive spread of the virus would have been significantly reduced to the point where vaccines would never have been needed.
It’s clear that throughout this pandemic, we’ve been dealing with agencies and leaders outside of the circle of empathy for compassion and consideration of the suffering, agony and despair suffered by the millions infected with Covid-19. Accountability is essential for the millions who suffered and died due to these blunders and crimes against humanity.
We never gave up. Instead, we channeled our anger into collective action by publishing a raw video of speeches that spoke the truth . . . and then posting and reposting, as the videos were repeatedly taken down.4
Despite the pushback, we won’t stop posting, until it is recognized all over the world that the public does not need to be afraid anymore.
There is an answer to Covid, and this is it.
Excerpted from Overcoming the Covid Darkness: How Two Doctors Successfully Treated 7000 Patients by Dr Brian Tyson and Dr George C Fareed.
|
References |
|
|
1 |
Am J Epidemiol, 2020; 189(11): 1218–26 |
|
2 |
“Statement of Harvey A. Risch, MD, PhD,” Nov 19, 2020, hsgac.senate.gov/hearings |
|
3 |
EMBL European Bioinformatics Institute, “CHEBI: 24869 – Ionophore,” Sept 20, 2021, ebi.ac.uk/chebi |
|
4 |
“Interview with Brian Tyson, MD, from California—a Pioneer of Outpatient Treatment for COVID-19,” Oct 2, 2020, https://youtu.be/fe1TqxvXKTs |
|
5 |
Publications and Preprint IHU, mediterranee-infection.com/pre-prints-ihu/ |
